Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

This publication has 79 references indexed in Scilit:

• Caspofungin Modulates Inflammatory Responses toAspergillus fumigatusthrough Stage‐Specific Effects on Fungal β‐Glucan Exposure
  The Journal of Infectious Diseases, 2008
• Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
  Clinical Infectious Diseases, 2008
• Editorial Commentary:Learning from Our Failures: The Antifungal Treatment Conundrum
  Clinical Infectious Diseases, 2008
• Trial Design for Mold-Active Agents: Time to Break the Mold--Aspergillosis in Neutropenic Adults
  Clinical Infectious Diseases, 2007
• Pretreatment with Empty Liposomes Attenuates the Immunopathology of Invasive Pulmonary Aspergillosis in Corticosteroid-Immunosuppressed Mice
  Antimicrobial Agents and Chemotherapy, 2007
• A Drug-Sensitive Genetic Network Masks Fungi from the Immune System
  PLoS Pathogens, 2006
• The Role of Immune Reconstitution Inflammatory Syndrome in AIDS‐RelatedCryptococcus neoformansDisease in the Era of Highly Active Antiretroviral Therapy
  Clinical Infectious Diseases, 2005
• Infusion‐related toxicity of three different amphotericin B formulations and its relation to cytokine plasma levels
  Mycoses, 1995
• Itraconazole therapy for nonmeningeal coccidioidomycosis: Clinical and laboratory observations
  Journal of the American Academy of Dermatology, 1990
• Miconazole in the Treatment of Coccidioidomycosis
  Drugs, 1983